[{"_id":"5641e95bfd1ef1594b89d1f5","決算期":"2007年5月期","証券コード":"3379","会社名":"(株)富士バイオメディックス【3379】","会計方式":"日本方式","決算発表日":"2007年7月12日","決算月数":"12か月","売上高":"18,215百万円","営業利益":"1,000百万円","経常利益":"834百万円","当期利益":"337百万円","EPS（一株当たり利益）":"4,917.36円","調整一株当たり利益":"4,911.42円","BPS（一株当たり純資産）":"73,240.29円","総資産":"23,690百万円","自己資本":"5,271百万円","資本金":"2,092百万円","有利子負債":"13,086百万円","自己資本比率":"22.2%","ROA（総資産利益率）":"1.77%","ROE（自己資本利益率）":"7.63%","総資産経常利益率":"4.38%","日付":"2015-11-10T12:55:56.628Z"},{"_id":"5641e95bfd1ef1594b89d1f6","決算期":"2008年5月期","証券コード":"3379","会社名":"(株)富士バイオメディックス【3379】","会計方式":"日本方式","決算発表日":"2008年7月25日","決算月数":"12か月","売上高":"29,496百万円","営業利益":"2,229百万円","経常利益":"1,521百万円","当期利益":"-2,275百万円","EPS（一株当たり利益）":"-25,878.79円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"74,950.64円","総資産":"36,676百万円","自己資本":"8,695百万円","資本金":"5,186百万円","有利子負債":"19,366百万円","自己資本比率":"23.7%","ROA（総資産利益率）":"-7.54%","ROE（自己資本利益率）":"-32.58%","総資産経常利益率":"5.04%","日付":"2015-11-10T12:55:56.628Z"},{"_id":"5641e95bfd1ef1594b89d1f7","決算期":"2006年5月期","証券コード":"3379","会社名":"(株)富士バイオメディックス【3379】","会計方式":"日本方式","決算発表日":"2006年7月10日","決算月数":"12か月","売上高":"12,031百万円","営業利益":"787百万円","経常利益":"677百万円","当期利益":"333百万円","EPS（一株当たり利益）":"5,215.02円","調整一株当たり利益":"5,137.58円","BPS（一株当たり純資産）":"59,591.51円","総資産":"14,430百万円","自己資本":"3,559百万円","資本金":"1,290百万円","有利子負債":"7,248百万円","自己資本比率":"24.7%","ROA（総資産利益率）":"3.00%","ROE（自己資本利益率）":"13.24%","総資産経常利益率":"6.10%","日付":"2015-11-10T12:55:56.629Z"}]